In a groundbreaking decision, a French court has officially acknowledged cosmic radiation as a contributing factor to the breast cancer diagnosis of former Air France flight attendant Sophie Lainault. This marks the first time such a link has been established for an airline employee. Lainault, aged 59, had sought recognition of her cancer as an occupational disease due to workplace conditions. The court in Bayonne identified cosmic radiation, passive smoking, and prolonged night work as carcinogenic hazards associated with her profession. The ruling allows Lainault, who is currently in remission, to retire early and receive full reimbursement for any further treatment from the French health system. By recognizing breast cancer as an occupational risk for flight crews, the court has paved the way for numerous similar claims, according to legal professionals. Lainault, a seasoned stewardess with over 12,600 flight hours under her belt (more than half of which were night flights), was frequently exposed to intense radiation near the North Pole during long-distance high-altitude flights from Paris. A recent study at Harvard Medical School revealed that flight attendants and pilots have the highest rate of radiation-related cancer deaths among over 500 professions, with about 6.9% of flight attendant deaths and 6.7% of pilot deaths attributed to radiation-related cancers. Despite the known link between air travel at high altitudes and cosmic radiation exposure, the dose for most travelers is generally considered statistically insignificant. However, exposure at the poles is more intense due to the lack of the Earth's magnetic field as a shield. This landmark decision marks the first time a connection between breast cancer and certain hazards has been established for an air hostess in France. Air France distanced itself from Lainault's legal case, stating that it had no involvement and was not privy to the court's reasoning. The company emphasized its commitment to employee health and safety, ensuring comprehensive medical support beyond regulatory requirements.